An inhibitor of platelet aggregation
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
Prostaglandin D3 (PGD3) is produced by the metabolism of EPA via the COX pathway. It is equipotent to PGD2 in decreasing systemic blood pressure in rats and in decreasing intraocular pressure in rabbits. However, it is 3-5 times more potent than PGD2 in the inhibition of ADP-induced human platelet aggregation.
N-(4-acetamidophenyl)-Indomethacin amide
¥220.00 ¥275.00
没有评价数据